Hypertension Case Presentation
Hypertension Case Presentation
Hypertension Case Presentation
HYPERTENSION
Group 4
Case:
A 35 year old man presents with a blood pressure of
150/90 mmHg. He has been generally healthy, is sedentary,
drinks several cocktails per day and does not smoke cigarettes.
He has a family history of hypertension and his father died of
Myocardial Infarction at age 55. Physical examination is
remarkable only for moderate obesity. Total cholesterol is 220
and HDL cholesterol level is 40mg/dL. Fasting glucose
175mg/dL. Chest x-ray is normal. ECG shows LV
enlargement.
📌Elevated blood
pressure
📌 Sedentary lifestyle
1.
📌 Alcohol intake
📌 Family history
📌 Obesity
What are the
📌 Increased
risk factors of cholesterol level
▣ Diabetes mellitus
📌 Difficulty of
breathing
2. 📌 Fatigue
📌 Vision problems
Signs and 📌 Severe headache
symptoms of
📌 Irregular
the disease? heartbeat
3. A thorough
cardiovascular
assessment
What will you
find in the
physical exam? IAPePa
Physical Exam
📌 Blood chemistry
5. 📌 HbA1c
📌 Serum electrolyte
Definition:
▣Systolic BP of >140 mm Hg
and/or
Diastolic BP of >90 mm Hg on
more than one occasion.
High
sodium,
cholesterol
and Psychologi
saturated fat cal and
intake environmen
tal stressors
Hypertension
Genetic
Old age
Clinical manifestation
▣ asymptomatic
▣ when symptoms appear, they usually indicate
vascular damage
▣ coronary artery disease with angina
▣ left ventricular hypertrophy
▣ left ventricular failure
▣ pathologic changes in the kidneys may be
manifested by nocturia.
▣ cerebral vascular involvement
Diagnostic evaluation
GOAL:
To achieve and maintain an arterial blood pressure
below 140/90 mm Hg whenever possible.
Nonpharmacologic approaches:
▣ Weight reduction
▣ Restriction of sodium, tobacco and alcohol
▣ Exercise
▣ Relaxation
Management
▣ Medications
Diuretics
Beta blockers
▣ Hospital management:
action. 📌 Statins
Thiazide
□ MOA
Inhibits sodium/Cl
symporter
(Acts on DCT)
Enhanced NaCl
excretion.
Captopril
□ MOA
Inhibits enzyme (ACE, increase in
kininase II, pedtidyl endogenous
dipeptidase) vasodilators (kinin)
BP is regulated
Statins
□ MOA:
- competitively inhibiting HMG-CoA reductase
- mimic the natural substrate molecule, HMG-CoA, and
compete for binding to the HMGCR enzyme.